Literature DB >> 2913038

Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States.

C M Patton1, N Shaffer, P Edmonds, T J Barrett, M A Lambert, C Baker, D M Perlman, D J Brenner.   

Abstract

Catalase-negative or weakly positive (CNW) thermotolerant campylobacteria, first isolated from dogs in 1983, were recently recognized as a new species, "Campylobacter upsaliensis," but their association with human illness has not been established. Twelve human isolates received at the Centers for Disease Control between 1980 and 1986 were identified as CNW campylobacteria by biochemical tests, cellular fatty acid composition, and antimicrobial susceptibility patterns. Eleven CNW Campylobacter strains tested by DNA-DNA hybridization (hydroxyapatite method) were all highly related and were related to two "C. upsaliensis" strains at the species level (86% under optimal conditions and 76% under stringent conditions). Clinical information was obtained for 11 human isolates from three stool and eight blood specimens. They were isolated from four female and seven male patients 6.5 months to 83 years of age residing in 10 different states. The patients had a wide spectrum of illnesses. The stool isolates were obtained from two previously healthy persons during episodes of acute gastroenteritis and from one immunocompromised patient with persistent diarrhea and fever. The blood isolates were obtained from two infants with fever and respiratory symptoms; a young woman with a ruptured ectopic pregnancy; three elderly men with underlying chronic diseases; and two immunocompromised adults. In a bactericidal assay to assess sensitivity to serum, seven of eight blood isolates showed some resistance to killing by pooled normal human serum. These observations suggest that "C. upsaliensis" is a potential human pathogen associated with both gastroenteritis and bacteremia in normal hosts and with opportunistic infection in immunocompromised individuals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2913038      PMCID: PMC267234          DOI: 10.1128/jcm.27.1.66-73.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Practical procedure for demonstrating bacterial flagella.

Authors:  H Kodaka; A Y Armfield; G L Lombard; V R Dowell
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

2.  Differential characteristics of catalase-positive campylobacters correlated with DNA homology groups.

Authors:  R M Roop; R M Smibert; J L Johnson; N R Krieg
Journal:  Can J Microbiol       Date:  1984-07       Impact factor: 2.419

Review 3.  Campylobacter enteritis.

Authors:  M J Blaser; L B Reller
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

4.  Comparison of the Penner and Lior methods for serotyping Campylobacter spp.

Authors:  C M Patton; T J Barrett; G K Morris
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

5.  Illness associated with Campylobacter laridis, a newly recognized Campylobacter species.

Authors:  R V Tauxe; C M Patton; P Edmonds; T J Barrett; D J Brenner; P A Blake
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

7.  Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds.

Authors:  D J Brenner; A C McWhorter; J K Knutson; A G Steigerwalt
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

8.  DNA relatedness and biochemical features of Campylobacter spp. isolated in central and South Australia.

Authors:  T W Steele; N Sangster; J A Lanser
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

9.  Isoprenoid quinone content and cellular fatty acid composition of Campylobacter species.

Authors:  C W Moss; A Kai; M A Lambert; C Patton
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

10.  Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.

Authors:  M J Blaser; P F Smith; P F Kohler
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

View more
  42 in total

1.  Campylobacter troglodytis sp. nov., isolated from feces of human-habituated wild chimpanzees (Pan troglodytes schweinfurthii) in Tanzania.

Authors:  Taranjit Kaur; Jatinder Singh; Michael A Huffman; Klára J Petrzelková; Nancy S Taylor; Shilu Xu; Floyd E Dewhirst; Bruce J Paster; Lies Debruyne; Peter Vandamme; James G Fox
Journal:  Appl Environ Microbiol       Date:  2011-01-28       Impact factor: 4.792

2.  Comparison of six media, including a semisolid agar, for the isolation of various Campylobacter species from stool specimens.

Authors:  H P Endtz; G J Ruijs; A H Zwinderman; T van der Reijden; M Biever; R P Mouton
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  In vitro susceptibility of "Campylobacter upsaliensis" to twenty-four antimicrobial agents.

Authors:  M A Preston; A E Simor; S L Walmsley; S A Fuller; A J Lastovica; K Sandstedt; J L Penner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

4.  Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene.

Authors:  C L Pickett; E C Pesci; D L Cottle; G Russell; A N Erdem; H Zeytin
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  First case report of fatal sepsis due to Campylobacter upsaliensis.

Authors:  Itaru Nakamura; Nami Omori; Ayaka Umeda; Kiyofumi Ohkusu; Tetsuya Matsumoto
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

6.  Evaluation of the indoxyl acetate hydrolysis test for the differentiation of Campylobacters.

Authors:  D S Hodge; A Borczyk; L L Wat
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Diarrheal Mechanisms and the Role of Intestinal Barrier Dysfunction in Campylobacter Infections.

Authors:  Fábia Daniela Lobo de Sá; Jörg-Dieter Schulzke; Roland Bücker
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

8.  Characterization and description of "Campylobacter upsaliensis" isolated from human feces.

Authors:  H Goossens; B Pot; L Vlaes; C Van den Borre; R Van den Abbeele; C Van Naelten; J Levy; H Cogniau; P Marbehant; J Verhoef
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  High-resolution genotyping of Campylobacter upsaliensis strains originating from three continents.

Authors:  P Lentzsch; B Rieksneuwöhner; L H Wieler; H Hotzel; I Moser
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Occurrence of plasmids in "Campylobacter upsaliensis" (catalase negative or weak group) from geographically diverse patients with gastroenteritis or bacteraemia.

Authors:  R J Owen; J Hernandez
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.